Krystal Biotech, Inc.
Public
KRYS
SectorHealthcare
CountryUnited States
Market cap8.04B
Krystal Biotech, Inc.,A commercial-stage gene therapy company utilizing proprietary viral vector platforms to develop treatments for rare and severe dermatological diseases.
